Indivior PLC $INDV Stock Bought by Artemis Investment Management LLP

Key Points

• Artemis Investment Management increased its Indivior stake by 214.8% in the third quarter, bringing its holdings to 48,231 shares valued at approximately $1.73 million. Institutional investors collectively own 60.33% of the company.
• Analyst sentiment remains positive overall, with Indivior carrying a consensus “Buy” rating and an average price target of $45.17, although Weiss Ratings downgraded the stock to “Hold” and Barclays reduced its target to $43.
• Indivior shares opened at $35.45, compared with a 52-week range of $22.95 to $42.81. The company also announced a special dividend of $8.13 per share, payable November 6 to shareholders of record as of October 30.

Artemis Investment Management LLP lifted its position in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 214.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 48,231 shares of the company's stock after purchasing an additional 32,912 shares during the period. Artemis Investment Management LLP's holdings in Indivior were worth $1,729,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd lifted its position in shares of Indivior by 72.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,093 shares of the company's stock worth $39,000 after buying an additional 460 shares in the last quarter. Rockefeller Capital Management L.P. grew its holdings in shares of Indivior by 512.4% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,286 shares of the company's stock valued at $46,000 after acquiring an additional 1,076 shares in the last quarter. TD Waterhouse Canada Inc. bought a new position in shares of Indivior in the second quarter valued at approximately $63,000. GAMMA Investing LLC purchased a new stake in shares of Indivior during the second quarter valued at approximately $66,000. Finally, Kemnay Advisory Services Inc. purchased a new stake in shares of Indivior during the fourth quarter valued at approximately $155,000. 60.33% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

INDV has been the topic of a number of recent analyst reports. Weiss Ratings cut Indivior from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Thursday, September 24th. Craig Hallum restated a "buy" rating and set a $53.00 price target on shares of Indivior in a research report on Tuesday, August 4th. Zacks Research upgraded shares of Indivior from a "hold" rating to a "strong-buy" rating in a report on Friday, October 2nd. Finally, Barclays lowered their price objective on shares of Indivior from $46.00 to $43.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $45.17.

Insider Buying and Selling at Indivior

In other news, CAO Woodrow D. Anderson purchased 1,500 shares of the stock in a transaction dated Thursday, August 27th. The shares were purchased at an average cost of $35.69 per share, with a total value of $53,535.00. Following the completion of the acquisition, the chief accounting officer owned 27,638 shares in the company, valued at $986,400.22. This represents a 5.74% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.74% of the stock is currently owned by corporate insiders.

Indivior Price Performance

Shares of INDV opened at $35.45 on Friday. The firm has a market cap of $4.18 billion, a PE ratio of 12.71 and a beta of 0.87. The stock's fifty day moving average price is $36.35 and its two-hundred day moving average price is $36.56. Indivior PLC has a 1 year low of $22.95 and a 1 year high of $42.81.

Indivior (NASDAQ:INDV - Get Free Report) last posted its quarterly earnings results on Tuesday, June 30th. The company reported $5.75 earnings per share for the quarter. The company had revenue of $343.00 million during the quarter. Indivior had a negative return on equity of 283.11% and a net margin of 26.65%. Sell-side analysts anticipate that Indivior PLC will post 3.66 earnings per share for the current fiscal year.

Indivior Announces Dividend

The business also recently disclosed a special dividend, which will be paid on Friday, November 6th. Investors of record on Friday, October 30th will be paid a dividend of $8.13 per share. The ex-dividend date is Friday, October 30th.

Indivior Company Profile

Indivior PLC NASDAQ: INDV is a specialty pharmaceutical company focused on developing and commercializing treatments for substance use disorders and serious mental health conditions. The company's primary focus is opioid use disorder, with products designed to support patients through medication-assisted treatment and recovery.

Indivior's portfolio includes Sublocade, an extended-release injectable formulation of buprenorphine; Suboxone, a buprenorphine and naloxone product available in sublingual formulations; and Perseris, an extended-release injectable formulation of risperidone for schizophrenia.

Want to see what other hedge funds are holding INDV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Indivior PLC (NASDAQ:INDV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.